← Clinical Evidence

SRC-239ca17a9991 Szwedo AA 2025

Evidence source and scope

Szwedo AA, Dalen I, Lawson RA, et al. Dementia risk prediction in early Parkinson's disease: Validation and genetic integration of the Montreal Parkinson risk of dementia scale (MoPaRDS). Journal of Parkinson's Disease. 2025. DOI 10.1177/1877718X251329857

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1177/1877718x251329857

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Szwedo AA, Dalen I, Lawson RA, et al. Dementia risk prediction in early Parkinson's disease: Validation and genetic integration of the Montreal Parkinson risk of dementia scale (MoPaRDS). Journal of Parkinson's Disease. 2025. DOI 10.1177/1877718X251329857

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — gait

GaitP108,P147-149:1108,350dementia,6incidentcohorts,max10.8y,timeROC9.5y;AUC.79(.75-.83);cut>=4sens21.7spec94.9;fall/freezingunivariatesignificantbutnotallitemmodel;0.5missingitemimputation and deathcensoring explicit;NYPUM/ICICLEoverlap. Source locator: s2StudyPopulation;s5RiskScores;s6Outcome;s7StatisticalAnalysis;s8Table1;s9ValidationTables2-3 Limit: SupplementTable5 underlyingitem estimates not inspected;mainResults explicit on which4items remainsignificant. No rawdiagnostic sensitivity substitution for time-dependentestimate.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide